Tumor
Group
|
|
|
|
BIOMARKERS
|
|
.
|
Lipp ES, McLendon RE.
Tissue is the Issue: Biomarkers of
Prognosis and Classification in Adult Gliomas.
Semin
Oncol Nurs. 2018 Dec;34(5):430-442. doi:
10.1016/j.soncn.2018.10.002. Epub 2018 Nov 6.
Source
| Full
text |
Similar
articles
|
|
|
DNA
METHYLATION PATTERNS
|
|
|
Chen X, Zhao C, Zhao Z, Wang H, Fang Z.
Specific Glioma
Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
Front Genet. 2019 Sep 12;10:786. doi:
10.3389/fgene.2019.00786.
Source
.
Similar
articles
|
|
|
EDEMA
|
|
|
Wu
CX, Lin GS, Lin ZX, Zhang JD, Chen L, Liu SY, Tang WL, Qiu XX,
Zhou CF.
Peritumoral
edema on magnetic resonance imaging predicts a poor clinical
outcome in malignant glioma.
Oncol
Lett. 2015 Nov;10(5):2769-2776. Epub 2015 Aug 25.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
NEUTROPHIL-TO-LYMPHOCYTE
RATIO
|
|
|
Lei YY, Li YT, Hu QL, Wang J, Sui AX.
Prognostic impact
of neutrophil-to-lymphocyte ratio in gliomas: a systematic review
and meta-analysis.
World J Surg Oncol. 2019 Aug
31;17(1):152. doi: 10.1186/s12957-019-1686-5.
Source
.
Similar
articles
|
|
|
MARITAL
STATUS
|
|
.
|
Long S, Li M, Ou S, Li G.
The effect of marital status on
glioma patient survival: analysis of 617 cases: A SEER-based
study.
Medicine (Baltimore). 2018 Dec;97(52):e13900.
doi: 10.1097/MD.0000000000013900.
Source
| Full
text | Similar
articles
|
|
|
PET
IMAGING
|
|
.
|
Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F,
Scopinaro F, Minniti G.
18F-DOPA uptake
does not correlate with IDH mutation status and 1p/19q co-deletion
in glioma.
Ann Nucl Med. 2019 Jan 3. doi:
10.1007/s12149-018-01328-3. [Epub ahead of print]
Source
| Full
text | Similar
articles
|
|
|
.
|
Kong Z, Lin Y, Jiang C, Li L, Liu Z, Wang Y, Dai C, Liu D, Qin X,
Wang Y, Liu Z, Cheng X, Tian J, Ma W.
18F-FDG-PET-based
Radiomics signature predicts MGMT promoter methylation status in
primary diffuse glioma.
Cancer Imaging. 2019 Aug
19;19(1):58. doi: 10.1186/s40644-019-0246-0.
Source
.
Similar
articles
|
|
|
|
Mitamura
K, Yamamoto Y, Kudomi N, Maeda Y, Norikane T, Miyake K, Nishiyama
Y.
Intratumoral
heterogeneity of 18F-FLT
uptake predicts proliferation and survival in patients with newly
diagnosed gliomas.
Ann
Nucl Med. 2016 Sep 29. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
SURGICAL
OUTCOMES
|
|
|
Ampie
L, Choy W, DiDomenico JD, Lamano JB, Williams CK, Kesavabhotla K,
Mao Q, Bloch O.
Clinical
attributes and surgical outcomes of angiocentric gliomas.
J
Clin Neurosci. 2016 Jun;28:117-22. doi:
10.1016/j.jocn.2015.11.015. Epub 2016 Jan 8.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Patel CK, Vemaraju R, Glasbey J, Shires J, Northmore T, Zaben M,
Hayhurst C.
Trends in peri-operative performance status
following resection of high grade glioma and brain metastases: The
impact on survival.
Clin Neurol Neurosurg. 2017 Dec
1;164:67-71. doi: 10.1016/j.clineuro.2017.11.016. [Epub ahead of
print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Tan
ZR, Long XY, Yang ZQ, Huang J, Hu QY, Yang HD, Li GL.
Younger
age at surgery and lesser seizure frequency as prognostic factors
for favorable seizure-related outcome after glioma resection in
adults.
Oncotarget.
2017 Jun 27. doi: 10.18632/oncotarget.18726. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RADIO/CHEMOTHERAPY
OUTCOMES
|
|
|
Qi
L, Ding L, Wang S, Zhong Y, Zhao D, Gao L, Wang W, Lv P, Xu Y,
Wang S.
A
network meta-analysis: the overall and progression-free survival
of glioma patients treated by different chemotherapeutic
interventions combined with radiation therapy (RT).
Oncotarget.
2016 Jul 21. doi: 10.18632/oncotarget.10763. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
REIRRADIATION
|
|
|
Krauze AV, Peters C, Cheng J, Ning H, Mackey M, Rowe L,
Cooley-Zgela T, Smart DD, Camphausen K.
Re-irradiation
for recurrent glioma- the NCI experience in tumor control, OAR
toxicity and proposal of a novel prognostic scoring system.
Radiat Oncol. 2017 Nov 29;12(1):191. doi:
10.1186/s13014-017-0930-9.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Lévy S, Chapet S, Scher N, Debbi K, Ruffier A, Bernadou G,
Pointreau Y, Calais G.
Reirradiation of gliomas under
stereotactic conditions: Prognostic factors for survival without
relapse or side effects, a retrospective study at Tours regional
university hospital (France).
Cancer Radiother. 2017
Dec;21(8):759-765. doi: 10.1016/j.canrad.2017.05.006. Epub 2017
Nov 8.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Navarria P, Minniti G, Clerici E, Tomatis S, Pinzi V, Ciammella P,
Galaverni M, Amelio D, Scartoni D, Scoccianti S, Krengli M, Masini
L, Draghini L, Maranzano E, Borzillo V, Muto P, Ferrarese F,
Fariselli L, Livi L, Pasqualetti F, Fiorentino A, Alongi F, di
Monale MB, Magrini S, Scorsetti M.
Re-irradiation for
recurrent glioma: outcome evaluation, toxicity and prognostic
factors assessment. A multicenter study of the Radiation Oncology
Italian Association (AIRO).
J Neurooncol. 2018 Dec 4.
doi: 10.1007/s11060-018-03059-x. [Epub ahead of print]
Source
| Full
text | Similar
articles
|
|
|
SURVIVAL
|
|
|
Bose R, Narang KS, Bhangale D, Kedia R, Sharma V, Jha AN.
Survival trends in glioma: Experience at a tertiary care
centre.
Neurol India. 2017 Nov-Dec;65(6):1295-1301. doi:
10.4103/0028-3886.217968.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Terziev R, Petrirena G, Marie Y, Mueller WC, Bielle F, Delattre
JY.
Posterior fossa recurrence of WHO grade II and III
supratentorial gliomas.
Rev Neurol (Paris). 2018 Oct 9.
pii: S0035-3787(17)30583-0. doi: 10.1016/j.neurol.2017.10.018.
[Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
ALLERGY
|
|
.
|
Lehrer S, Rheinstein PH, Rosenzweig KE.
Allergy may
confer better survival on patients with gliomas.
Clin
Neurol Neurosurg. 2019 Feb;177:63-67. doi:
10.1016/j.clineuro.2018.12.021. Epub 2018 Dec 31.
Source
| Full
text | Similar
articles
|
|
|
WHO
grade II and III supratentorial gliomas
|
|
.
|
Terziev R, Petrirena G, Marie Y, Mueller WC, Bielle F, Delattre
JY.
Posterior fossa recurrence of WHO grade II and III
supratentorial gliomas.
Rev Neurol (Paris). 2018 Oct 9.
pii: S0035-3787(17)30583-0. doi: 10.1016/j.neurol.2017.10.018.
[Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|
